{{item.title}}
{{item.text}}
{{item.title}}
{{item.text}}
In this study, PwC assesses the current quality approach of biopharmaceutical, hardware and software medical device organisations of all sizes and ages to explore commonalities and differences, and identify opportunities to improve and enhance patient and business outcomes through quality.
Take part in this global quality survey and share your insights.
For organisations subject to stringent biopharmaceutical and medical device regulations, quality has been evolving over the past years from a compliance-centric approach to increasingly include product-quality and innovation-centric philosophies thus becoming more and more patient centric. The following three stages of quality approaches can be observed in this development:
We at PwC are passionate to support biopharmaceutical and medtech organisations to move towards a more patient-centric quality approach, providing patients with a reliable supply of products, access to more innovative products, and improved compliance and product quality.
Senior Consultant, Pharma and Life Science, PwC Switzerland
Tel: +41 58 792 48 45